Reuters logo
BRIEF-Galena Biopharma jumps in premarket on marketing deal with Teva Pharma
December 4, 2012 / 1:01 PM / 5 years ago

BRIEF-Galena Biopharma jumps in premarket on marketing deal with Teva Pharma

NEW YORK, Dec 4 (Reuters) - Galena Biopharma Inc : * Up 13.7 percent to $2.32 in premarket on marketing deal with Teva Pharmaceutical Industries Ltd

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below